CELC Stock Analysis: Buy, Sell, or Hold?
CELC - Celcuity Inc. Common Stock
$107.95
3.46 (3.31%)
▲
5d:
+12.53%
30d:
+18.08%
90d:
-4.41%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Smart Money Distribution
None View Scanner →
Strength: 4.7/10
Get Alerted When CELC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
🚀 STRONG BUY: CELC shows excellent value with unusually cheap options (IV 14th percentile) and market pricing in only 0.6% annual growth despite strong fundamentals. High conviction opportunity.
🚀 STRONG BUY: CELC shows excellent value with unusually cheap options (IV 14th percentile) and market pricing in only 0.6% annual growth despite strong fundamentals. High conviction opportunity.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$25.92
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$16.10
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CELC is currently trading at $107.95, which is considered fair relative to its 30-day fair value range of $84.34 to $116.09. The stock's valuation (Forward PE: 145.9) is in line with its historical norms (143.1). At these levels, the market is pricing in 0.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CELC is showing sideways momentum. The price is approaching resistance at $108.32. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: CELC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $160.64 (+48.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CELC is showing sideways momentum. The price is approaching resistance at $108.32. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: CELC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $160.64 (+48.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$84.34 -
$116.09
Company Quality Score
55/100
(HOLD)
Options IV Signal
14th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
91.2%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 14th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- BULLISH: Trading 48.8% below Wall St target ($160.64)
- NEUTRAL: Market pricing in 0.6% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$84.34 -
$116.09
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$10.59
(9.8%)
Support & Resistance Levels
Support Level
$82.55
Resistance Level
$108.32
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
145.88
Wall Street Target
$160.64
(+48.8%)
Valuation Premium vs History
+0.6% premium
PE vs Historical
145.9 vs 143.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$108.60
(+1%)
2-Year Target
$109.25
(+1%)
3-Year Target
$109.90
(+2%)
3-Yr Target (if PE normalizes)
(PE: 146→143)
PE COMPRESSION
$107.81
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 03, 2026 3:48 PM ET
Data refreshes hourly during market hours. Next update: 4:48 PM
Data refreshes hourly during market hours. Next update: 4:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard E Buller
SELL
3000 shares
2026-03-31
David Dalvey
SELL
20000 shares
2026-01-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 67 BUY |
Advanced CELC Option Strategies
Professional options setups generated by AI based on today's CELC price and gamma walls.
